Table 1.
Relationship between comorbidities and NUP37 or MCM2 expression in HCC patients (n = 300)
| Variable | NUP37 | MCM2 | ||||
|---|---|---|---|---|---|---|
| Low | High | p-value | Low | High | p-value | |
| Hypertension | ||||||
| No | 153 | 71 | 0.338 | 159 | 65 | 0.121 |
| Yes | 46 | 30 | 46 | 30 | ||
| Diabetes | ||||||
| No | 183 | 89 | 0.384 | 187 | 85 | 0.787 |
| Yes | 16 | 12 | 18 | 10 | ||
| Liver cirrhosis | ||||||
| No | 176 | 93 | 0.233 | 185 | 84 | 0.781 |
| Yes | 23 | 8 | 20 | 11 | ||
| Fatty liver | ||||||
| No | 182 | 86 | 0.140 | 184 | 84 | 0.883 |
| Yes | 17 | 15 | 21 | 11 | ||
| Portal vein hypertension | ||||||
| No | 185 | 89 | 0.233 | 188 | 86 | 0.906 |
| Yes | 14 | 12 | 17 | 9 | ||
| Hepatitis B virus | ||||||
| No | 59 | 20 | 0.806 | 56 | 23 | 0.895 |
| Yes | 160 | 61 | 153 | 68 | ||
HCC, hepatocellular carcinoma